Comparison of the hepatotoxicity of low-molecular-weight versus unfractionated heparin for anticoagulation therapy after digital replantation

다국어 초록 (Multilingual Abstract)

Purpose: Unfractionated heparin (UFH) is more commonly used as an anticoagulant after digital replantation than low-molecular-weight heparin (LMWH). We compared the success and complication rates of these two anticoagulants, since only a few studies have made this comparison directly. Methods: Forty-four patients who underwent digital replantation for complete or incomplete digital amputation in the past 7 years at a single institution were included. The patients were divided into LMWH and UFH groups according to the anticoagulant administered. The success rates for each group were obtained, and the postoperative serum aspartate aminotransferase (AST) and alanine transaminase (ALT) levels were analyzed to compare the complication rates. Results: All patients, except one, had successful recovery of circulation after replantation, and the success rate did not show a statistically significant difference between the two groups. The statistical analysis showed that the proportion of patients with abnormal serum AST or ALT levels in the LMWH group was significantly lower than that in the UFH group. Conclusion: Although there was no significant difference in the success rate between the two groups, the risk of hepatotoxicity was significantly lower in the LMWH group than in the UFH group. Considering the advantages of LMWH, its extensive use is highly recommended for anticoagulation therapy in patients after digital replantation.

참고문헌 (Reference)

1 Bounameaux H, "Unfractionated versus low-molecular-weight heparin in the treatment of venous thromboembolism" 3 : 41-46, 1998

2 Solari F, "StatPearls" StatPearls Publishing 2020

3 Gouin-Thibault I, "Safety profile of different low-molecular weight heparins used at therapeutic dose" 28 : 333-349, 2005

4 Meneveau N, "Safety evaluation of enoxaparin in currently approved indications" 8 : 745-754, 2009

5 Pomerance J, "Replantation and revascularization of the digits in a community microsurgical practice" 13 : 163-170, 1997

6 Baker EL, "Probable enoxaparin-induced hepatotoxicity" 66 : 638-641, 2009

7 Kaciulyte J, "Postsurgical antithrombotic therapy in microsurgery : our protocol and literature review" 23 : 4448-4457, 2019

8 Rodríguez Vegas JM, "PGE-1 in replantation and free tissue transfer : early preliminary experience" 27 : 395-397, 2007

9 Hirsh J, "Low-molecular-weight heparin : a review of the results of recent studies of the treatment of venous thromboembolism and unstable angina" 98 : 1575-1582, 1998

10 Lin PT, "Low molecular weight heparin for prevention of microvascular occlusion in digital replantation" 4 : CD009894-, 2020

11 Nozawa H, "Liver injury among Japanese patients treated using prophylactic enoxaparin after colorectal surgery" 66 : 2805-2815, 2021

12 Bosco M, "Hepatotoxicity with elevated bilirubin secondary to prophylactic doses of unfractionated heparin : a case report and review of heparin-induced hepatotoxicity" 35 : 36-40, 2019

13 AL-Mekhaizeem KA, "Heparin-induced hepatotoxicity" 15 : 527-530, 2001

14 Young E, "Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin" 71 : 300-304, 1994

15 Hahn KJ, "Enoxaparin-induced liver injury : case report and review of the literature and FDA Adverse Event Reporting System(FAERS)" 2 : 17-, 2015

16 Zaera De La Fuente C, "Enoxaparin-induced hepatotoxicity" 38 : 438-439, 2015

17 Carlson MK, "Elevation of hepatic transaminases after enoxaparin use : case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity" 21 : 108-113, 2001

18 Maeda M, "Continuous local intra-arterial infusion of antithrombotic agents for replantation(comparison with intravenous infusion)" 44 : 520-525, 1991

19 Vretos KA, "Antithrombotic and antinflammatory drugs for protection of microvascular anastomosis" 264 : 48-49, 1995

20 Jokuszies A, "Anticoagulative strategies in reconstructive surgery : clinical significance and applicability" 10 : Doc01-, 2012

21 Haney JS, "A severe case of idiosyncratic hepatotoxicity with unfractionated heparin" 56 : 777-785, 2021